Cimpress plc CMPR
79.79
1.18
1.50%
as of 25 Sep
- Market cap
- $1.9B
- P/E
- 20.4×
Follow CMPR
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
25.94 | 39.04 | 68.65 | 44.71 |
+8 more quarters Free account |
P/S ratio |
0.66 | 0.48 | 0.46 | 0.45 | |
P/FCF ratio |
19.05 | 13.54 | 10.58 | 9.45 | |
P/Operating CF |
22.48 | (107.19) | 9.94 | 61.82 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.01 | 0.87 | 0.83 | 0.85 | |
EV/EBITDA |
9.37 | 7.96 | 7.68 | 7.77 | |
EV/Operating CF |
13.30 | 11.30 | 9.68 | 9.22 | |
EV/FCF |
28.94 | 24.25 | 19.21 | 17.93 | |
Quick Ratio |
0.42 | 0.36 | 0.40 | 0.37 | |
Current Ratio |
0.73 | 0.68 | 0.68 | 0.65 | |
Net Debt/EBITDA |
12.03 | 16.01 | 10.58 | 16.05 | |
Debt/Assets |
72.52% | 76.65% | 75.33% | 80.03% | |
Debt/Equity |
(3.37) | (3.01) | (2.98) | (2.76) | |
Asset Turnover |
1.79 | 1.86 | 1.78 | 1.80 | |
Operating CF/Net income |
4.41 | (1.19) | 3.34 | 3.28 | |
Capex/Depreciation |
(0.97) | (1.02) | (1.10) | (1.17) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
9.70% | 9.80% | 8.55% | 9.83% | |
Selling, General and Administrative Expense of Revenue |
28.35% | 30.18% | 29.40% | 30.63% | |
Intangible Assets out of Total Assets |
0.42 | 0.42 | 0.42 | 0.45 | |
Share Based Compensation of Revenue |
1.60% | 1.65% | 1.61% | 1.71% | |
Graham Net Nets |
(0.85) | (1.18) | (1.26) | (1.32) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
3.85% | 2.56% | 1.46% | 2.24% | |
Free Cash Flow Yield |
5.25% | 7.39% | 9.45% | 10.58% | |
Revenue per Share |
38.69 | 36.53 | 42.42 | 35.13 | |
Operating CF per Share |
4.52 | (0.68) | 6.70 | 1.02 | |
Capex per Share |
(1.64) | (1.57) | (1.64) | (1.74) | |
Free Cash Flow per Share |
2.89 | (2.25) | 5.06 | (0.72) | |
Cash per Share |
13.20 | 7.79 | 10.50 | 8.16 | |
Shareholders Equity per Share |
(19.40) | (21.60) | (21.57) | (23.22) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(19.40) | (21.60) | (21.57) | (23.22) | |
Free Cash Flow |
70.48 | (54.62) | 124.33 | (17.76) | |
Working Capital |
(211.14) | (234.19) | (264.92) | (265.37) | |
Capital Expenditures |
(40.03) | (38.10) | (40.33) | (42.82) | |
Net Current Asset Value |
(2,111.90) | (2,083.20) | (2,063.24) | (2,047.96) | |
EV/EBIT |
15.03 | 12.60 | 12.22 | 12.45 | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.05 | |
Net Profit Margin |
2.65% | 1.56% | 4.73% | 0.88% | |
Price to Operating Income |
9.90 | 7.04 | 6.73 | 6.57 | |
| Other line items | |||||
Average Receivables |
— | 69.40 | 64.73 | 76.24 | |
Average Payables |
332.68 | 303.66 | 347.25 | 307.84 | |
Average Inventory |
124.93 | 112.86 | 113.03 | 114.96 | |
Average Assets |
2,085.33 | 1,966.61 | 2,006.14 | 1,925.24 | |
Average Common Equity |
(528.17) | (540.34) | (541.86) | (570.48) |
Columns are period end dates